PMC:7195088 / 22875-23181 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"680","span":{"begin":142,"end":150},"obj":"Species"},{"id":"681","span":{"begin":193,"end":201},"obj":"Species"},{"id":"682","span":{"begin":275,"end":283},"obj":"Species"},{"id":"813","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"814","span":{"begin":164,"end":175},"obj":"Chemical"},{"id":"815","span":{"begin":212,"end":222},"obj":"Chemical"},{"id":"816","span":{"begin":294,"end":305},"obj":"Chemical"},{"id":"947","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"948","span":{"begin":184,"end":192},"obj":"Disease"}],"attributes":[{"id":"A680","pred":"tao:has_database_id","subj":"680","obj":"Tax:9606"},{"id":"A681","pred":"tao:has_database_id","subj":"681","obj":"Tax:9606"},{"id":"A682","pred":"tao:has_database_id","subj":"682","obj":"Tax:9606"},{"id":"A813","pred":"tao:has_database_id","subj":"813","obj":"MESH:C462182"},{"id":"A814","pred":"tao:has_database_id","subj":"814","obj":"MESH:C462182"},{"id":"A815","pred":"tao:has_database_id","subj":"815","obj":"MESH:C086979"},{"id":"A816","pred":"tao:has_database_id","subj":"816","obj":"MESH:C462182"},{"id":"A947","pred":"tao:has_database_id","subj":"947","obj":"MESH:C000657245"},{"id":"A948","pred":"tao:has_database_id","subj":"948","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T20","span":{"begin":27,"end":30},"obj":"Body_part"},{"id":"T21","span":{"begin":41,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T111","span":{"begin":17,"end":26},"obj":"Disease"},{"id":"T112","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T113","span":{"begin":184,"end":192},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T112","span":{"begin":71,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T113","span":{"begin":97,"end":98},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T270","span":{"begin":41,"end":65},"obj":"Chemical"},{"id":"T271","span":{"begin":56,"end":65},"obj":"Chemical"},{"id":"T272","span":{"begin":164,"end":175},"obj":"Chemical"},{"id":"T273","span":{"begin":212,"end":222},"obj":"Chemical"},{"id":"T274","span":{"begin":294,"end":305},"obj":"Chemical"}],"attributes":[{"id":"A270","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A271","pred":"chebi_id","subj":"T271","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A272","pred":"chebi_id","subj":"T272","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A273","pred":"chebi_id","subj":"T273","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A274","pred":"chebi_id","subj":"T274","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-sentences","denotations":[{"id":"T170","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}